GGrantIndex
Sort

17,828 grants matching crispr

Traumatic axonopathy and Alzheimer tau propagation

$450,313
Vassilis E Koliatsos · Johns Hopkins University · R21 · FY2023 · NS

Genomic Editing & Screening

$450,273
Ralph J. Garippa · Sloan-Kettering Inst Can Research · P30 · FY2019 · CA

Systematic Functional Interpretation of Regulatory Variants in Schizophrenia

$450,261
Jubao Duan · Endeavor Health Clinical Operations · R01 · FY2020 · MH

Regulation of blood-retina barrier by placental growth factor

$450,252
Hu Huang · Wake Forest University Health Sciences · R01 · FY2025 · EY

Generation and analysis of new mouse models to determine novel therapeutic targets for Down syndrome-associated cognitive deficits

$450,011
Eugene Yu · Roswell Park Cancer Institute Corp · R01 · FY2024 · HD

Mechanistic investigation of DNA cleavage and specificity in CRISPR-Cas9

$450,000
Giulia Palermo · University Of California-Riverside · · FY2019 · MPS

CHEMICAL COUNTERMEASURES FOR CRISPR-CAS9/CPF1 ENZYMES

$450,000
Brigham & Womens Hospital Inc · · FY2016 · Department of the Army

Understanding chromatin modulation of copy number and rereplication

$449,927
Johnathan R. Whetstine · Research Inst Of Fox Chase Can Ctr · R01 · FY2020 · GM

CRISPR-Cas13-based rapid HIV-1 test

$449,888
Peter B Lillehoj · Rice University · R61 · FY2024 · AI

Role of phospho UBC9 in alcohol-associated liver disease

$449,870
Maria Lauda Tomasi · Cedars-Sinai Medical Center · R01 · FY2022 · AA

Unlocking mechanisms of resistance to targeted therapy in thyroid cancer

$449,823
Myriem Boufraqech · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Molecular Pathogenesis of AF10-Rearranged Leukemias

$449,812
Aniruddha J. Deshpande · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · CA

Project 2: The GABP-TERT axis in immortality of Oligodendroglioma and Glioblastoma

$449,799
Joseph F Costello · University Of California, San Francisco · P01 · FY2021 · CA

Project 1: Role of the H3K27 demethylase KDM6A in bladder cancer pathogenesis

$449,777
David B. Solit · Columbia University Health Sciences · P01 · FY2019 · CA

Generation and analysis of new mouse models to determine novel therapeutic targets for Down syndrome-associated cognitive deficits

$449,608
Eugene Yu · Roswell Park Cancer Institute Corp · R01 · FY2025 · HD

Role of StAR-related lipid transfer protein 10 in alcohol-induced breast cancer progression

$449,496
Maria Lauda Tomasi · Cedars-Sinai Medical Center · R01 · FY2023 · AA

Investigating the heterogeneity of glucose transport in lung adenocarcinoma

$449,420
Claudio Scafoglio · University Of California Los Angeles · R01 · FY2022 · CA

Developing a CRISPR-based forward-genetic screening method in embryonic zebrafish

$449,350
Jonathon T Hill · Brigham Young University · R15 · FY2024 · HD

APEX2-mediated Identification of factors involved in seeding by tau protein

$449,333
Marc I Diamond · Ut Southwestern Medical Center · R21 · FY2020 · AG

Beyond GWAS of insulin resistance: An integrated approach to translate genetic association to function

$449,308
Erik Ingelsson · Stanford University · R01 · FY2017 · DK

Molecular Pathogenesis of AF10-Rearranged Leukemias

$449,276
Aniruddha J. Deshpande · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · CA

Glyoxalase 1 and its Role in Metabolic Syndrome

$449,263
James J Galligan · University Of Arizona · R01 · FY2024 · DK

Fluomics: The Next Generation

$449,250
Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2021 · AI

Three-dimensional organoid models to study breast cancer progression

$449,186
Shilpa Sant · University Of Pittsburgh At Pittsburgh · R37 · FY2020 · CA

Control of Histone mRNA Levels

$449,174
William F Marzluff · Univ Of North Carolina Chapel Hill · R01 · FY2022 · GM